View News
'Virginia Life Science Investments' invests in 9 Israeli companies in first year
Outgrowth of Virginia Israel Bio Commercialization Center; working with 12 Israeli companies.
Posted 08/01/2010
On July 1, 2010 Virginia Life Science Investments, LLC (VLSI) began its second year of operations. During their first year of business, VLSI in conjunction with a investment group which provided the recapitalization for a portfolio company, raised over $18 million.
VLSI has invested in eight Israeli companies (and is working with twelve). The companies include medical device companies, diagnostic companies and platform technologies that are in various stages of development. VLSI is in the process of establishing a ninth company and expects to co-invest in this start up with a venture incubator in Israel. The VLSI investor base is made up of a broad range of investors from both the U.S. and Israel.